For those who are interested in knowing what the future of CHP research holds, take a look at this short research highlight from the Department of Defense- Congressionally Directed Medical Research Programs. It showcases our Co-Founder Dr. Michael Yu (University of Utah) and his collaborator Dr. Martin Pomper's (John's Hopkins University) research to explore how CHPs can be used to target prostate cancer! This is just one application of CHPs that is be...
Biotechnology company 3Helix, Inc. ("3Helix") announced today that it has received over 1.4 Million US Dollars of a Phase II Small Business Innovation Research (SIBR) grant from the National Institutes of Health (NIH) to develop its proprietary Collagen Hybridizing Peptide agent for detecting damaged collagen in histological and pre-clinical studies. This two-year project, funded by the Office of Research Infrastructure Programs (ORIP) of NIH, will allo...
To help spread the knowledge about CHPs and their usefulness, 3Helix is excited to announce that we have published a new article on Wikipedia! This will allow people of all backgrounds to learn about collagen hybridizing peptides in an easy to understand way. We hope that the Wikipedia page will be a starting place for researchers who have never heard of CHPs or those who would like to learn more!
Check out the CHP WIKIPEDIA PAGE
...
3Helix is excited and proud to announce that we have new distributors worldwide, making it even easier for you to try out our CHP products in your research! Now you can order CHPs Worldwide from Antibodies Online, in India from OSB Life Sciences, in The UK from Caltag Medsystems, in Italy from DBA Italia, in China from Dakewe, in Germany from Holzel Diagnostika, and in Australia from Assay Matrix. 3Helix wants to thank our new distributors and are thri...
We are excited to announce that we have teamed up with great distributors that will help researchers obtain CHPs worldwide! We currently have distributors in Canada (Cedarlane), Japan (Funakoshi), The UK/Europe (2B Scientific), The Netherlands/Europe (IQ Products), and Germany/Europe (Biozol). We are excited about the opportunity to work with these great companies and hope that their customers enjoy our CHP products for imaging denatured collagen!
...
We are excited to announce that 3Helix has rolled out a new CHP for histology! We now offer R-CHP, which has a sulfo-Cyanine 3 conjugated onto it. The R-CHP has an excitation/emission of 548/563 nm which will fluoresce in the red channel. It still has high specificity for denatured collagen and follows the same protocol as the F-CHP. Now you can image denatured collagen in the red (R-CHP) or green (F-CHP) channels on your favorite fluorescence microsco...
3Helix is proud to be a sponsor for the upcoming Collagen Gordon Research Conference 2019 at Colby-Sawyer College! If you have the opportunity we highly recommend attending from July 14-19th. This is an intimate conference that allows you multiple opportunities to meet with speakers and share new scientific ideas involving collagen. Our founder, Dr. Michael Yu, will be in attendance, so bring your questions!
Check out the full schedule and who...
Our founders and inventors of the CHP for 3Helix, Dr.'s Yang Li and Michael Yu, published a chapter titled "In Situ Detection of Degraded and Denatured Collagen via Triple Helical Hybridization: New Tool in Histopathology" in Collagen!! They are thankful for the co-editors and the tremendous contributions of all authors and experts of the field that made this volume possible. They hope that this book on collagen will be a useful tool for scientists wor...
